ICGex

Grünewald, T.G.P. et al.
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Nature Genetics. 2015
doi:

Bellini A. et al.
Deep sequencing reveals occurrence of sub-clonal ALK mutations in neuroblastoma at diagnosis
Clin. Cancer Res. 2015
doi:

Smith M.J. et al.
Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis
Neurology. 2015
doi:

Manfrini N. et al.
RNA-processing proteins regulate Mec1/ATR activation by promoting generation of RPA-coated ssDNA
EMBO Rep. 2015
doi:

Goudot C. et al.
Aryl Hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages.
Immunity (2017) Sep. 47(3):582-596.e6.
doi: 10.1016/j.immuni.2017.08.016

Cabel L. et al.
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-conceptstudy.
Ann Oncol. (2017) Aug. 28(8):1996-2001.
doi: 10.1093/annonc/mdx212

Pincez T. et al.
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.
Pediatr Blood Cancer (2017) Jun. 64(6).
doi: 10.1002/pbc.26365

Le Tourneau C. et al.
The SHIVA01 trial: what have we learned?
Pharmacogenomics (2017) Jun. 18(9):831-834.
doi: 10.2217/pgs-2017-0062

Richer W. et al.
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers.
Oncotarget (2017) May. 8(21):34245-34257.
doi: 10.18632/oncotarget.15939